Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£ |
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Keryx Biopharmaceuticals, Inc. |
(Registrant) |
Date: May 4, 2006 |
By:
/s/ Ronald C. Renaud,
Jr.
|
Ronald C. Renaud, Jr. |
Senior Vice President, Chief Financial Officer, Secretary and Treasurer |
Exhibit
Number
|
Description
|
99.1
|
Press Release dated May 4, 2006. |